The Medical Letter on Drugs and Therapeutics
				
			FROM
ISSUE 1521
    
   			ISSUE 1521
May 22, 2017
                			
                		 Issue 1521
                		- Prescription Drug Prices in the US
 - Valbenazine (Ingrezza) for Tardive Dyskinesia
 - Oxymetazoline Cream (Rhofade) for Rosacea
 - FDA Warns Against Use of Codeine and Tramadol in Children and Breastfeeding Women
 - Another Subcutaneous Immune Globulin (Cuvitru) for Primary Immunodeficiency (online only)
 - Vonvendi - Recombinant von Willebrand Factor (online only)
 - Comparison Table: Some Topical Drugs for Rosacea (online only)
 
					Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
				
				Prescription Drug Prices in the US
May 22, 2017 (Issue: 1521)
				Per capita spending on prescription drugs in the US is
higher than in other industrialized nations, including
Canada.
        			
        			
					
					
				
        			
				The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
				